Procos brings synthesis expertise to scale up conference
Press Release | Procos S.p.A.
JUNE 24, 2016
Cameri, Italy: – Leading Italian contract manufacturer (CMO) Procos will present its latest insights on synthesizing Active Pharmaceutical Ingredients to the Scale Up of Processes Conference at Lake Maggiore.
Procos, previously a Gold Sponsor of the event will be a high profile presence at the event, which is taking place close to its advanced research and manufacturing site at Cameri. This will allow the company to offer delegates a guided tour of the newly upgraded Cameri facility as a supporting activity during the afternoon of Day Two.
R&D Lab Director Dr. Jacopo Roletto will present a keynote address on Day Two of the conference. Dr. Roletto’s talk on ‘Agomelatine: Synthesis and Polymorphism Challenges’ will address various aspects of patent strategy, polymorphism challenges and scale up issues on industrial reactors with capacity 4000 – 6000 liters for Reformatsky Reactions. He will also be showing how borohydride can be used to handle reduction steps, overcoming frequently encountered industrial scale problems, as well as how to set up inherently safe processes.
Dr. Roletto is an eminent industrial chemist who graduated with honors from the Universities of Turin and Milan. Now Director of Procos R&D Laboratories, he leads all R&D projects, managing the laboratory group of 16 researchers.
With the R&D laboratory team, Dr. Roletto is involved in management of several projects for custom manufacturing, including various major pharma customers, as well as generic products. He has authored or co-authored 14 International or national patent applications and six scientific publications.
Procos will also be an exhibitor at the Scale Up Conference with a stand in the Sala Marte exhibition area. The exhibition runs concurrently with the conference and will host refreshment and lunch breaks.
Procos will also use the exhibition zone to host a welcome Networking Reception on the first evening of the conference, starting at 1745 hours.
The Procos team at the Scale Up Conference will be headed by CEO Dr. Enrico Zodio and will also include Sales & Marketing Director Kingo Yamashita and R&D and Business Development Director Dr. Paolo Paissoni.
Procos S.p.A. is an Italian Contract Research and Manufacturing Organization (CRO, CMO) that specializes in development, scale-up and production of active ingredients and advanced intermediates for the pharmaceutical industry.
Procos is an important member of the international CBC Group, headquartered in Japan. This network provides Procos with global reach, reinforced with subsidiary sales offices in the USA, Slovakia, Germany and India.
Over 70 years, Procos has built up a comprehensive range of technologies and capabilities to provide high quality products and services that have been widely accepted in worldwide pharmaceutical markets. It continuously develops and adds unique generic APIs and key intermediates to its product portfolio.
Procos’ two core business sectors are the development and supply of active pharmaceutical ingredients (APIs) and GMP advanced intermediates along with contract manufacturing services.
Procos manufactures more than 30 products, mostly under uniquely designed synthetic methods and under strict regulatory compliance management. In contract manufacturing, Procos provides related services for the pharmaceutical industry acting as a CRO/CMO for custom synthesis on exclusive base, supporting customer from early clinical stage up to full -scale commercial production. Development services include IP analysis expertise and effective patent challenge skills.
Innovation is a driving force of Procos’ activities. The company’s products are based on patented technologies and cost-effective processes. Procos chemistry expertise is focused on the most complex organic reactions, including organo-metallic catalysis, multi-catalytic hydrogenation, Enantioselective and hazardous chemistry.
About Process Chemistry Conference
The Scale-Up of Chemical Processes Conference was founded in 1994 to focus on crystallization, which is recognized as one of the most difficult pharmaceutical unit operations to control.
It has since become a major international forum for the discussion of all aspects of crystallization and scale-up in the pharmaceutical, fine chemical and allied fields.
The conference caters for chemists, chemical engineers, QA and safety specialists looking to achieving greater process efficiency, yield and throughput and reduce cost while eliminating unsafe and non-sustainable processes and materials.
The 2016 conference is a three-day event opening June 27 at the Grand Hotel Dino in Baveno, on the shores of Lake Maggiore in Northern Italy.
Key Topics for the 2016 will include QbD, DoE and CSTRs. The conference will feature numerous key speakers, case studies and generous networking facilities.
The conferences is organized by Scientific Update magazine with more information at: https://scientificupdate.co.uk/index.php/conferences/conferences-and-workshops/details/283-scale-up-of-chemical-processes.html
Kingo Yamashita, Sales & Marketing Director, Procos SpA
Tel: +39 0321 642211
Click on Procos brings synthesis expertise to scale up conference for other information.
Click on Procos to contact the company directly.